Cargando…

Chromatin Remodelling Molecule ARID1A Determines Metastatic Heterogeneity in Triple-Negative Breast Cancer by Competitively Binding to YAP

SIMPLE SUMMARY: Heterogeneity is a prominent characteristic of triple-negative breast cancer, and it remains the predominant cause of treatment failure. ARID1A, a key subunit of the nuclear SWI/SNF protein complex, plays a crucial role in determining tumour identity by manipulating gene expression....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ye, Chen, Xinyu, Qiao, Xiaosu, Xie, Yizhao, Guo, Duancheng, Li, Bin, Cao, Jianing, Tao, Zhonghua, Hu, Xichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177047/ https://www.ncbi.nlm.nih.gov/pubmed/37173914 http://dx.doi.org/10.3390/cancers15092447

Ejemplares similares

ARID2 Chromatin Remodeler in Hepatocellular Carcinoma
por: Loesch, Robin, et al.
Publicado: (2020)

Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer
por: Wang, Jinyan, et al.
Publicado: (2022)

Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma
por: Wang, Jinyan, et al.
Publicado: (2023)

A study of clinical and molecular characteristics in bilateral primary breast cancer
por: Li, Bin, et al.
Publicado: (2023)

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
por: Hillmer, Ryan E., et al.
Publicado: (2019)

Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes
por: Wu, Mei-Yi, et al.
Publicado: (2008)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a “PET biopsy” method
por: Xie, Yizhao, et al.
Publicado: (2019)

Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice
por: Han, Lin, et al.
Publicado: (2019)

Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma
por: Robinson, M. Hope, et al.
Publicado: (2019)

Heterogeneity derived from (18)F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients
por: Xie, Yizhao, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
por: Li, Bin, et al.
Publicado: (2023)

Mutant SRF and YAP1 remodel the chromatin to entice cardiac myocyte nuclear division
por: Marian, Ali J.
Publicado: (2022)

Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of (18)F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
por: Gong, Chengcheng, et al.
Publicado: (2022)

Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer
por: Li, Yi, et al.
Publicado: (2019)

Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types
por: Jones, Siân, et al.
Publicado: (2012)

Downregulation of ARID1A, a component of the SWI/SNF chromatin remodeling complex, in breast cancer
por: Takao, Chika, et al.
Publicado: (2017)

Calcium dynamics and chromatin remodelling underlie heterogeneity in prolactin transcription
por: Harper, Claire V, et al.
Publicado: (2020)

Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
por: Chen, Huey-Miin, et al.
Publicado: (2022)

Chromatin remodeler ARID1A binds IRF3 to selectively induce antiviral interferon production in macrophages
por: Hu, Ye, et al.
Publicado: (2021)

Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
por: Jiang, Dongfang, et al.
Publicado: (2023)

Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression
por: Duan, Yujie, et al.
Publicado: (2016)

KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling
por: Yu, Bo, et al.
Publicado: (2022)

YAP: The nexus between metabolism and cardiac remodeling
por: Gao, Chen, et al.
Publicado: (2022)

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy
por: Zhang, Jian, et al.
Publicado: (2015)

Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy
por: Zhang, Fang-Lin, et al.
Publicado: (2022)

Multiple functions of SWI/SNF chromatin remodeling complex in plant-pathogen interactions
por: Jian, Yunqing, et al.
Publicado: (2021)

Investigating avian competition for surface water in an arid zone bioregion
por: Votto, Simon E., et al.
Publicado: (2023)

Chromatin remodeling in oligodendrogenesis
por: Antontseva, E.V., et al.
Publicado: (2021)

Cardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturation
por: Boogerd, Cornelis J., et al.
Publicado: (2023)

Cut the YAP: Limiting Fibrosis in Pathologic Cardiac Remodeling
por: Small, Eric M., et al.
Publicado: (2020)

ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling
por: Liu, Yun, et al.
Publicado: (2021)

Single-molecule imaging of chromatin remodelers reveals role of ATPase in promoting fast kinetics of target search and dissociation from chromatin
por: Kim, Jee Min, et al.
Publicado: (2021)

Pretreatment (18)F‐FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer
por: Ma, Guang, et al.
Publicado: (2023)

ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines
por: Khursheed, M, et al.
Publicado: (2013)

Chromatin remodeling and genome stability
por: Barkess, Gráinne
Publicado: (2006)

Chromatin remodelling comes into focus
por: Sundaramoorthy, Ramasubramian, et al.
Publicado: (2020)

Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer
por: Jia, Zhenya, et al.
Publicado: (2018)

Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data
por: Gong, Chengcheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p34vgfff5c47nh10ttrgdqgi1q